Почетна › Рак дојке › Северна Каролина › Winston-Salem
Kliničke studije za Рак дојке u gradu Winston-Salem, NC
15 studija za Рак дојке traži učesnike na lokacijama u gradu Winston-Salem i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Тражи се учесникФаза 3
- Novant Health Cancer Institute, Winston-Salem
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Тражи се учесникОпсервациона студија
- Wake Forest NCORP Research Base, Winston-Salem
- Wake Forest University Health Sciences, Winston-Salem
- Wake Forest University at Clemmons, Clemmons · 9 ми удаљено
Distance-Based Exercise to Preserve Function and Prevent Disability
Тражи се учесник
- Novant Health Forsyth Medical Center, Winston-Salem
- Novant Health Cancer Institute - Kernersville, Kernersville · 10 ми удаљено
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Тражи се учесникФаза 3
- Novant Health Forsyth Medical Center, Winston-Salem
- Wake Forest University Health Sciences, Winston-Salem
- Novant Health Colon and Rectal Clinic, Clemmons · 9 ми удаљено
- и још 2
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Тражи се учесникФаза 3
- Novant Health Oncology Specialists ( Site 0074), Winston-Salem
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Тражи се учесникОпсервациона студија
- Atrium Health Wake Forest Baptist Medical Center, Winston-Salem
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
Тражи се учесникФаза 2
- Comprehensive Cancer Center at Wake Forest University (CCCWFU), Winston-Salem
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Тражи се учесникФаза 1/2
- Novant Health Oncology Specialists, Winston-Salem
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Тражи се учесникФаза 3
- Atrium Health Wake Forest Baptist, Winston-Salem
- Wake Forest Baptist Hematology and Oncology - Clemmons, Clemmons · 9 ми удаљено
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Тражи се учесникФаза 3
- Research Site, Winston-Salem
Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial
Тражи се учесник
- Wake Forest NCORP RB, Winston-Salem
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Тражи се учесникФаза 2
- Atrium Health Wake Forest Baptist - Comprehensive Cancer Center, Winston-Salem
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Тражи се учесникФаза 2
- Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Тражи се учесникФаза 3
- Novant Health Forsyth Medical Center, Winston-Salem
- Wake Forest University Health Sciences, Winston-Salem
- Wake Forest University at Clemmons, Clemmons · 9 ми удаљено
- и још 1
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Тражи се учесникОпсервациона студија
- Massive Bio SYNERGY-AI site, Winston-Salem
Studije za Рак дојке u drugim gradovima
- New York City, NY144 студија
- Houston, TX126 студија
- Boston, MA110 студија
- Nashville, TN78 студија
- Los Angeles, CA73 студија
- Edison, NJ70 студија
- Queens, NY67 студија
- Durham, NC63 студија
- St. Louis, MO63 студија
- Chicago, IL59 студија
- Dallas, TX54 студија
- Philadelphia, PA51 студија
Ostale studije u gradu Winston-Salem
- Akutna mijeloidna leukemija20 студија
- Рак (све врсте)19 студија
- Многи мијелом16 студија
- Кардиоваскуларне болести13 студија
- Немалоклетни карцином плућа11 студија
- ХОБП11 студија
- Рак јајника10 студија
- Мијелопролиферативни неоплазми9 студија
- Мијелофиброза9 студија
- Dijabetes tipa 29 студија
- Мијелодиспластични синдроми9 студија
- Hronična limfocitna leukemija9 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.